Elanco Animal Health Incorporated
ELAN
$21.43
-$0.29-1.34%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 120.65% | -711.76% | -409.09% | -83.58% | 937.50% |
| Total Depreciation and Amortization | -1.19% | 0.00% | 4.35% | 5.92% | -1.30% |
| Total Amortization of Deferred Charges | 0.00% | -25.00% | 0.00% | -11.11% | -10.00% |
| Total Other Non-Cash Items | 413.33% | -183.33% | 260.00% | 0.00% | 114.29% |
| Change in Net Operating Assets | -216.89% | 281.36% | 13.46% | 121.94% | -523.21% |
| Cash from Operations | -87.96% | -50.68% | -7.59% | 6,025.00% | -102.26% |
| Capital Expenditure | 17.74% | 32.61% | -61.40% | 12.31% | -38.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | -- |
| Other Investing Activities | -350.00% | 77.78% | -1,000.00% | 150.00% | 0.00% |
| Cash from Investing | 6.25% | 36.63% | -80.36% | 3.45% | 35.56% |
| Total Debt Issued | -- | 626.21% | -- | -100.00% | -- |
| Total Debt Repaid | 99.24% | -1,020.74% | 57.85% | -150.56% | -368.42% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 11.76% | 93.33% | -187.93% | 4,242.86% | -216.67% |
| Cash from Financing | -261.11% | 88.24% | 1.92% | -400.00% | 262.50% |
| Foreign Exchange rate Adjustments | -135.71% | 1,300.00% | -96.30% | -6.90% | 137.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -392.50% | 217.65% | -165.38% | 173.68% | 186.36% |